Skip to content
GenoLensGenoLens

SETD1B

Chr 12q24.31

SET domain containing 1B, histone lysine methyltransferase

Aliases:
KIAA1076, Set1B, KMT2G
MANE:
ENST00000604567.6

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Early onset or syndromic epilepsy

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Disease associations (Open Targets)

  • intellectual developmental disorder with seizures and language delay

    0.78
  • hereditary disease

    0.52
  • neurodevelopmental disorder

    0.45
  • autosomal dominant non-syndromic intellectual disability

    0.37
  • complex neurodevelopmental disorder

    0.37
  • Abnormality of the skeletal system

    0.35
  • epilepsy

    0.28
  • escherichia coli infection

    0.27
  • Neurodevelopmental delay

    0.27
  • lung adenocarcinoma

    0.27

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Histone-lysine N-methyltransferase SETD1B

Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) via a non-processive mechanism (PubMed:17355966, PubMed:25561738). Part of chromatin remodeling machinery, forms H3K4me1, H3K4me2 and H3K4me3 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:17355966, PubMed:25561738). Plays an essential role in regulating the transcriptional programming of multipotent hematopoietic progenitor cells and lymphoid lineage specification during hematopoiesis (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.